[HTML][HTML] Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation
Q Wang, A Zeng, M Zhu, L Song - … journal of oncology, 2023 - spandidos-publications.com
… characteristics of dual inhibition of the EGFR‑VEGF pathway. … and mutated EGFR;
bronchial-pulmonary adenocarcinomas in … Bronchoalveolar lavage (BAL) is another method of …
bronchial-pulmonary adenocarcinomas in … Bronchoalveolar lavage (BAL) is another method of …
Targeted therapy and checkpoint immunotherapy in lung cancer
R Ruiz-Cordero, WP Devine - Surgical pathology clinics, 2020 - surgpath.theclinics.com
… with distinct morphologic features, mutation and transcriptomic … factor receptor; LUAD, lung
adenocarcinoma; LUSC, lung … RMB10, and MGA as the 10 most commonly mutated genes. …
adenocarcinoma; LUSC, lung … RMB10, and MGA as the 10 most commonly mutated genes. …
[HTML][HTML] A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers
… parallel viewing of morphological features of tumor cells under the … In lung adenocarcinomas,
HER2 mutations have been … In non-small cell lung cancer, anti-HER2 agents are approved …
HER2 mutations have been … In non-small cell lung cancer, anti-HER2 agents are approved …
Concomitant genetic alterations are associated with plasma D-dimer level in patients with non-small-cell lung cancer
F Chang, H Zhang, C Chen, Z Ke, M Zhao, X Fan… - Future …, 2022 - Future Medicine
… The receiver operating characteristic curve analysis indicated that … mutations for non-small-cell
lung cancer patients. … In this study, the proportion of adenocarcinoma in the wild-type …
lung cancer patients. … In this study, the proportion of adenocarcinoma in the wild-type …
Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
… as bronchioalveolar stem cells (BASCs) and alveolar type 2 (AT2) cells in the distal airways.
[ 1-3 ] Lung adenocarcinoma … with alveolar or bronchiolar features, which can originate from …
[ 1-3 ] Lung adenocarcinoma … with alveolar or bronchiolar features, which can originate from …
Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma–morphology, molecular characteristics and differential diagnosis
S Berezowska, M Maillard, M Keyter, B Bisig - Histopathology, 2024 - Wiley Online Library
… of lung cancer diagnosis and staging.Bronchial washings, bronchial brushings, collection of
sputum, bronchioalveolar … -mutated and ALK-rearranged lung adenocarcinomas following …
sputum, bronchioalveolar … -mutated and ALK-rearranged lung adenocarcinomas following …
[HTML][HTML] Next generation sequencing technology in lung cancer diagnosis
C Cainap, O Balacescu, SS Cainap, LA Pop - Biology, 2021 - mdpi.com
… adenocarcinoma, squamous cell carcinoma and large cell … to identify specific lung cancer
mutations in circulating tumor DNA, … These genes are EGFR, BRAF, KRAS, HER2, ROS, ALK, …
mutations in circulating tumor DNA, … These genes are EGFR, BRAF, KRAS, HER2, ROS, ALK, …
Advances in Diagnosis and Treatment of Neoplastic Ground-Glass Nodules
S Liu - Current Research in Medical Sciences, 2024 - pioneerpublisher.com
… lung cancer and gene mutations, data on adenocarcinomas in … bronchioloalveolar carcinoma.
It is characterized as a small … is a key feature of invasive adenocarcinoma presented as …
It is characterized as a small … is a key feature of invasive adenocarcinoma presented as …
Targeted therapy for non-small cell lung cancer
ZS Noor, AL Cummings, MKM Johnson… - … in Respiratory and …, 2020 - thieme-connect.com
… families based on molecular characteristics of their ligands and … to identify targetable mutations
in patients with NSCLC. … ALK NSCLC adenocarcinoma, those that harbor a fusion gene …
in patients with NSCLC. … ALK NSCLC adenocarcinoma, those that harbor a fusion gene …
[HTML][HTML] Inherited lung cancer: a review
VTL de Alencar, MN Formiga… - Ecancermedicalscience, 2020 - ncbi.nlm.nih.gov
… carcinoma, whereas adenocarcinoma is the most common type of … study of the
clinicopathological characteristics of 152 … [bronchoalveolar] cancer) diagnosed at age <46 years …
clinicopathological characteristics of 152 … [bronchoalveolar] cancer) diagnosed at age <46 years …